Study of JNP-0101 in patients with overactive bladder
Phase of Trial: Phase II
Latest Information Update: 04 Aug 2016
At a glance
- Drugs Oxybutynin (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Pharmacokinetics
- 04 Aug 2016 Results published in the Media Release.
- 11 Jan 2016 This trial is expected to begin in the second half of 2016, according to a Juniper Pharmaceuticals media release.
- 20 Nov 2015 New trial record